Ozempic Is a Hit. So Why Is the Drugmaker’s CEO Out?
The Journal.
00:00
Novo Nordisk: Navigating Nonprofit Oversight and Market Success
This chapter explores the unique nonprofit foundation structure of Novo Nordisk and its implications for corporate governance in Denmark. It also highlights the successful leadership of the CEO and the significant market impact of the weight-loss drug Ozempic.
Transcript
Play full episode
